天演藥業 ADAG 深 滬
等待開盤 09-22 09:30:00 美东时间
3.21
-0.100
-3.02%
華盛通- 最 高3.35
- 今 開3.34
- 成交量 9.78万股
- 最 低 3.18
- 昨 收 3.31
- 總市值 2.16亿
- 52周最高 4.85
- 市盈率 靜 --
- 換手率 0.15%
- 52周最低 1.30
- 委 比 57.75%
- 總股本 6714.33万
- 歷史最高 31.83
- 量 比 0.30
- 振 幅 5.14%
- 歷史最低 0.90
- 每 手 1
- 風險率 0.90%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多9月18日美股收盘：三大股指收涨 科技股推动大盘走高 油价下跌同样提振股市
美国股市周四上涨，受美国国债收益率和油价回落以及关键科技股走强支撑，交易员收复了前一交易日的失地，并摆脱了美联储三年来首次加息后的不安情绪。此前，美联储加息...
09-18 04:16
纳斯达克中国金龙指数涨超0.5%，爱奇艺涨7.87%
每经AI快讯，9月17日，纳斯达克中国金龙指数涨超0.5%，爱奇艺涨7.87%，燃石医学涨6.95%，天演药业涨6.15%，知乎涨5.35%，再鼎医药涨5.1...
09-17 23:48
美股大行评级 | 机构看淡消费股！麦当劳、耐克、卡夫亨氏齐遭降目标价；能源股获齐声唱多
今日重点评级关注：Ascendiant Capital：维持SurgePays"买入"评级，目标价从3.5美元升至3.75美元；HC Wainwright & Co.：维持Spero Therapeutics"买入"评级，目标价从5美元升至6美元
09-15 15:30
美股大行评级 | 齐声看好医药股！礼来、强生、默沙东目标价均获上调；小摩大幅上调Meta目标价至820美元
今日重点评级关注：康托·菲茨杰拉德：维持SOL Strategies"超配"评级，目标价从2.8美元升至6.2美元；康托·菲茨杰拉德：维持Sui Group Holdings"超配"评级，目标价从1.7美元升至3.4美元
09-11 14:30
Chardan Capital Initiates Coverage On Adagene with Buy Rating, Announces Price Target of $9
Chardan Capital analyst Gautam Chukka initiates coverage on Adagene (NASDAQ:ADAG) with a Buy rating and announces Price Target of $9.
09-10 19:47
Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates
Adagene Inc. announced the achievement of a milestone in its collaboration with Exelixis, Inc., resulting in a $2.0 million payment for the preclinical milestone of XB404, an antibody-drug conjugate utilizing Adagene's SAFEbody masking technology. Exelixis also triggered an additional payment by selecting candidates for another SAFEbody ADC program. Adagene is eligible for further development milestones, royalties, and commercialization payments....
09-09 12:00
Adagene to Participate in Three Upcoming Investor Conferences
Adagene Inc. announced that its senior management will participate in three upcoming investor conferences in New York: the 2026 Cantor Global Healthcare Conference on September 11, 2026; the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026; and the H.C. Wainwright 28th Annual Global Investment Conference on September 16, 2026. The events will include Fireside Chats and 1x1 meetings. Adagene, a biotechnology company sp...
08-20 12:00
天演药业（ADAG）上半年实现净收入160万美元 研发投入同比增16.2%
经济观察网 天演药业（ADAG）2026年上半年中报披露，其录得净收入且研发投入保持增长，净亏损同比有所扩大。 业绩经营情况： 8月13日发布中报：上半年净收入...
08-18 05:59
Adagene H1 Adj. EPS $(0.20) Misses $(0.10) Estimate, Sales $1.620M
Adagene (NASDAQ:ADAG) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.10) by 100 percent. This is a 5.26 percent decrease over losses of $(0.19) per share from the same period last year. The company reported $1.620 million in sales this quarter.
08-12 19:33
